Published in Biochemistry on June 30, 1998
The structure-activity relationships of A-ring-substituted aromathecin topoisomerase I inhibitors strongly support a camptothecin-like binding mode. Bioorg Med Chem (2010) 0.87
TDP1/TOP1 Ratio as a Promising Indicator for the Response of Small Cell Lung Cancer to Topotecan. J Cancer Sci Ther (2014) 0.81
Assessment of anti-cytogenotoxic effects of quercetin in animals treated with topotecan. Oxid Med Cell Longev (2011) 0.77
[Zn(phen)(O,N,O)(H2O)] and [Zn(phen)(O,N)(H2O)] with O,N,O is 2,6-dipicolinate and N,O is L-threoninate: synthesis, characterization, and biomedical properties. J Biol Inorg Chem (2012) 0.75
Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway. Oncogene (1999) 3.23
Eukaryotic mRNA cap binding protein: purification by affinity chromatography on sepharose-coupled m7GDP. Proc Natl Acad Sci U S A (1979) 2.81
Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage. N Engl J Med (1983) 2.63
gamma Ray induced deoxyribonucleic acid strand breaks. 3' Glycolate termini. J Biol Chem (1983) 2.41
Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol Cell Biol (1993) 2.40
Isolation and identification of four cytokinins from wheat germ transfer ribonucleic acid. Biochemistry (1970) 2.30
Cytokinins: synthesis, mass spectra, and biological activity of compounds related to zeatin. Proc Natl Acad Sci U S A (1969) 2.30
Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ (1991) 2.20
Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue. J Biol Chem (1994) 2.04
Rapamycin sensitivity in Saccharomyces cerevisiae is mediated by a peptidyl-prolyl cis-trans isomerase related to human FK506-binding protein. Mol Cell Biol (1991) 2.03
On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. Biochemistry (1989) 1.95
Evidence that DNA topoisomerase I is necessary for the cytotoxic effects of camptothecin. Mol Pharmacol (1988) 1.95
In-person vs telephone-administered multiple-pass 24-hour recalls in women: validation with doubly labeled water. J Am Diet Assoc (2000) 1.93
Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia. Cancer Res (1979) 1.93
A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns]. Science (1998) 1.86
Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole. Cancer Res (1980) 1.78
Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor. Cancer Res (1994) 1.75
Structure and mechanism of yeast RNA triphosphatase: an essential component of the mRNA capping apparatus. Cell (1999) 1.72
Cytokinin from soluble RNA of Escherichia coli: 6-(3-methyl-2-butenylamino)-2-methylthio-9-beta-D-ribofuranosylpurine. Science (1968) 1.66
Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme. J Biol Chem (1987) 1.66
Longitudinal changes in fatness in white children: no effect of childhood energy expenditure. Am J Clin Nutr (1998) 1.64
Influence of body composition on the accuracy of reported energy intake in children. Obes Res (2000) 1.59
Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity. J Med Chem (1989) 1.57
Ribonucleoside phosphates via phosphorimidazolidate intermediates. Synthesis of pseudoadenosine 5'-triphosphate. Biochemistry (1973) 1.40
Chemotherapy of human colon cancer xenografts in athymic nude mice. Cancer (1977) 1.39
Diaminobenzidine as a myelin stain in semithin plastic sections. Biotech Histochem (1999) 1.38
Specificity of deoxyribonucleic acid cleavage by bleomycin, phleomycin, and tallysomycin. Biochemistry (1982) 1.36
Cytokinins: development of a potent antagonist. Proc Natl Acad Sci U S A (1971) 1.32
Cytologic evidence that taxol, an antineoplastic agent from Taxus brevifolia, acts as a mitotic spindle poison. Cancer Treat Rep (1978) 1.31
Role of murine tumor models in cancer treatment research. Cancer Res (1986) 1.30
Cross-finger pedicle flaps in the hand. J Bone Joint Surg Am (1971) 1.29
Developmental changes in energy expenditure and physical activity in children: evidence for a decline in physical activity in girls before puberty. Pediatrics (1998) 1.28
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity. J Med Chem (1991) 1.28
Uptake and retention of adriamycin and daunorubicin by sensitive and anthracycline-resistant sublines of P388 leukemia. Biochem Pharmacol (1978) 1.26
CYTOKININS: SYNTHESIS OF 6-(3-METHYL-3-BUTENYLAMINO)-9-beta-D-RIBOFURANOSYLPURINE (3IPA), AND THE EFFECT OF SIDE-CHAIN UNSATURATION ON THE BIOLOGICAL ACTIVITY OF ISOPENTYLAMINOPURINES AND THEIR RIBOSIDES. Proc Natl Acad Sci U S A (1968) 1.26
Identification of quantitative trait loci affecting reproduction in pigs. J Anim Sci (2001) 1.24
Analysis of products formed during bleomycin-mediated DNA degradation. Biochemistry (1985) 1.22
The isolation and identification of two cytokinins from Escherichia coli transfer ribonucleic acids. Biochemistry (1969) 1.22
Cytokinin of wheat germ transfer RNA: 6-(4-hydroxy-3-methyl-2-butenylamino)-2-methylthio-9-beta-D-ribofuranosylpurine. Science (1969) 1.22
On the "activation" of cytokinins. J Biol Chem (1975) 1.22
Nonproductive rearrangement of DNA topoisomerase I and II genes: correlation with resistance to topoisomerase inhibitors. J Natl Cancer Inst (1989) 1.19
Anatomical course of the thenar branch of the median nerve--usually in a separate tunnel through the transverse carpal ligament. J Bone Joint Surg Am (1970) 1.19
"Chemical aminoacylation" of tRNA's. J Biol Chem (1978) 1.19
The effect of "cap" analogs on reovirus mRNA binding to wheat germ ribosomes. Evidence for enhancement of ribosomal binding via a preferred cap conformation. J Biol Chem (1978) 1.18
Metal ion and substrate structure dependence of the processing of tRNA precursors by RNase P and M1 RNA. J Biol Chem (1990) 1.17
Plakortides, novel cyclic peroxides from the sponge Plakortis halichondrioides: activators of cardiac SR-CA(2+)-pumping ATPase. J Nat Prod (1996) 1.17
Oligonucleotide N-alkylphosphoramidates: synthesis and binding to polynucleotides. Biochemistry (1988) 1.16
Chemical transformations of 7,9-disubstituted purines and related heterocycles. Selective reduction of imines and immonium salts. J Org Chem (1976) 1.16
Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro. J Natl Cancer Inst (1992) 1.16
Antitumor activity of N-(phosphonacetyl)-L-aspartic acid, a transition-state inhibitor of aspartate transcarbamylase. Cancer Res (1976) 1.16
T4 RNA ligase mediated preparation of novel "chemically misacylated" tRNAPheS. Biochemistry (1984) 1.15
In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia. Cancer Treat Rep (1978) 1.15
Mutational analysis of 39 residues of vaccinia DNA topoisomerase identifies Lys-220, Arg-223, and Asn-228 as important for covalent catalysis. J Biol Chem (1997) 1.14
Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I. Cancer Res (1988) 1.13
Site-specific cleavage of RNA by Fe(II).bleomycin. Proc Natl Acad Sci U S A (1990) 1.13
DNA sequence specificity of the pyrrolo[1,4]benzodiazepine antitumor antibiotics. Methidiumpropyl-EDTA-iron(II) footprinting analysis of DNA binding sites for anthramycin and related drugs. Biochemistry (1986) 1.12
Transport of antimicrobial agents using peptide carrier systems: anticandidal activity of m-fluorophenylalanine--peptide conjugates. J Med Chem (1983) 1.11
N 6 -( 2 -Isopentenyl)adenosine: the regulatory effects of a cytokinin and modified nucleoside from tRNA on human lymphocytes. Biochim Biophys Acta (1972) 1.11
Chemistry of the alkali-labile lesion formed from iron(II) bleomycin and d(CGCTTTAAAGCG). Biochemistry (1988) 1.09
Relationship between the intracellular effects of camptothecin and the inhibition of DNA topoisomerase I in cultured L1210 cells. Cancer Res (1987) 1.09
The pronator quadratus in motions and in stabilization of the radius and ulna at the distal radioulnar joint. J Hand Surg Am (1976) 1.08
In vitro and intracellular inhibition of topoisomerase II by the antitumor agent merbarone. Cancer Res (1989) 1.08
Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models. Cancer Res (1985) 1.07
Fat intake and adiposity in children of lean and obese parents. Am J Clin Nutr (1996) 1.06
Biological responses to porcine respiratory and reproductive syndrome virus in pigs of two genetic populations. J Anim Sci (2005) 1.05
Exposure of mice to topical bovine thrombin induces systemic autoimmunity. Am J Pathol (2001) 1.05
Differential immunity in pigs with high and low responses to porcine reproductive and respiratory syndrome virus infection. J Anim Sci (2007) 1.04
Yeast TOR (DRR) proteins: amino-acid sequence alignment and identification of structural motifs. Gene (1994) 1.03
Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content. Mol Pharmacol (1990) 1.03
Anti-Candida activity of polyoxin: example of peptide transport in yeasts. Antimicrob Agents Chemother (1984) 1.03
Effects of release factor 1 on in vitro protein translation and the elaboration of proteins containing unnatural amino acids. Biochemistry (1999) 1.02
Differences between normal and ras-transformed NIH-3T3 cells in expression of the 170kD and 180kD forms of topoisomerase II. Cancer Res (1990) 1.02
Estimation of genetic parameters for average daily gain using models with competition effects. J Anim Sci (2008) 1.01
In vitro and in vivo effects of clinically important camptothecin analogues on multidrug-resistant cells. Oncol Res (1993) 1.01
Structural studies of of "active complex" of bleomycin: assignment of ligands to the ferrous ion in a ferrous-bleomycin-carbon monoxide complex. Proc Natl Acad Sci U S A (1979) 1.01
Copper-dependent cleavage of DNA by bleomycin. Biochemistry (1987) 1.00
Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content. Oncol Res (1992) 1.00
Amino acid substitutions in protein biosynthesis. Poly(A)-directed polyphenylalanine synthesis. J Biol Chem (1980) 1.00
Experimental antitumor activity of aminoanthraquinones. Cancer Treat Rep (1979) 0.99
Synthesis and structure-activity relationships of cytotoxic 7-hydroxy sterols. J Nat Prod (1994) 0.99
Use of COMPARE analysis to discover new natural product drugs: isolation of camptothecin and 9-methoxycamptothecin from a new source. J Nat Prod (2000) 0.99
A model for topoisomerase I-mediated insertions and deletions with duplex DNA substrates containing branches, nicks, and gaps. Biochemistry (1995) 0.99
Antitumor activity of bis(diphenylphosphino)alkanes, their gold(I) coordination complexes, and related compounds. J Med Chem (1987) 0.99
Chemical modifications of transfer RNA species. Desulfurization with Raney nickel. Proc Natl Acad Sci U S A (1971) 0.99
Cytotoxicity and antitumor activity of some tetrahedral bis(diphosphino)gold(I) chelates. J Med Chem (1990) 0.99
Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in phosphodiesterase-deficient yeast. Mol Pharmacol (1991) 0.98
A chemical synthesis of adenosine 5'-(gamma-32P)triphosphate. Biochim Biophys Acta (1973) 0.98
Polynucleotide recognition and degradation by bleomycin. Prog Nucleic Acid Res Mol Biol (1994) 0.98
Biological activity of some coumarins from Sri Lankan Rutaceae. J Nat Prod (1994) 0.97
The CYP2 gene of Saccharomyces cerevisiae encodes a cyclosporin A-sensitive peptidyl-prolyl cis-trans isomerase with an N-terminal signal sequence. Gene (1991) 0.97
Control of the position of RNase P-mediated transfer RNA precursor processing. J Biol Chem (1990) 0.97
A genome scan for quantitative trait loci and imprinted regions affecting reproduction in pigs. J Anim Sci (2004) 0.97
Isomeric phenylalanyl-tRNAs. Position of the aminoacyl moiety during protein biosynthesis. Proc Natl Acad Sci U S A (1974) 0.97
Erythrocyte volume distribution in normal and abnormal subjects. Blood (1975) 0.97
Kinetic and mutational analysis of human immunodeficiency virus type 1 reverse transcriptase inhibition by inophyllums, a novel class of non-nucleoside inhibitors. J Biol Chem (1994) 0.96